Instructional Course - Requires Course Pass, Additional Registration Required

Instructional Course

031IC - Contemporary Pharmacotherapy for OAB

Saturday, May 19
10:00 AM - 12:00 PM
Location: MCC WEST, 2004

Much has been written and debated about drug treatment of overactive bladder (OAB) over the past two decades. Nevertheless, the field continues to evolve. OAB pharmacotherapy remains an area of active investigation and innovation. Patient communication, including goal setting with respect to realistic expectations of therapy, and therapeutic algorithms are important factors in improving patient outcomes. The publication of the recently updated AUA/SUFU Guideline entitled "Diagnosis and Treatment of Overactive Bladder (Non-neurogenic) in Adults, the proceedings of the 5th International Consultation on Incontinence," as well as European Association of Urology (EAU) Guidelines, has rekindled interest in this area. This course will describe the physiological and pharmacological underpinnings of modern drug treatment of overactive bladder including combination therapy. Currently available agents as well as drugs in development will be discussed.

Learning Objectives:

Eric S. Rovner

Medical University of South Carolina

Eric S. Rovner, M.D. is a Professor in the Department of Urology at the Medical University of South Carolina (MUSC) in Charleston, South Carolina. He is the director of the Section of Voiding Dysfunction, Female Urology and Urodynamics in the Department of Urology at MUSC. He has a highly specialized clinical practice within Urology and sees mostly patients with complex voiding problems including urinary incontinence, vaginal prolapse, urinary fistulae and neurogenic bladder dysfunction.

He is a Board Certified member of the American Urological Association, Fellow of the American College of Surgeons, as well as a member of the Society of Pelvic Surgeons, American Association of GU Surgeons, Society of University Urologists, and the Society for Urodynamics, Female Urology and Urogenital reconstruction (SUFU) among others. He was the President of SUFU from 2014-16. Dr. Rovner has served on several committees for the International Consultation on Incontinence and has been a member of the AUA Urodynamics Guidelines Committee, and SUI Guidelines Committee. He has served on the AUA/ABU Exam Committee as well as the ABU Oral Exam Committee.

Dr. Rovner’s research interests include the study of voiding dysfunction, overactive bladder, interstitial cystitis, lower urinary tract reconstruction, neurourology and urodynamics. He has held several visiting professorships and is the author of >150 peer-reviewed scientific articles, and >30 book chapters on these topics as well as books on urinary incontinence and urodynamics. He has been an invited speaker on numerous occasions throughout the United States and the world, and has been the Principal or co-investigator on multiple NIDDK/NIH as well as industry sponsored grants.

Presentation(s):

Send Email for Eric Rovner

Christopher R. Chapple

Sheffield Teaching Hospitals NHS Foundation Trust, University of Sheffield, Sheffield Hallam University

Christopher Chapple is a Consultant Urological Surgeon at Sheffield Teaching Hospitals, Honorary Professor at University of Sheffield and Visiting Professor at Sheffield Hallam University. He is particularly interested in functional reconstruction of the lower urinary tract and the underlying pharmacological control mechanisms, and provides a tertiary service in lower urinary tract reconstructive surgery. He trained at the Middlesex Hospital where he completed his doctorate thesis. He continued there and the Institute of Urology in London for his sub-specialist training. He is Secretary General of the European Association of Urology, having previously been Chairman of the International Relations Committee, Adjunct Secretary General Responsible for Education, and Director of the European School of Urology. He is the Coordinator of the European Reference Network (ERN) for rare urogenital diseases and complex conditions (eUROGEN); a network of 29 healthcare providers across Europe. He was editor-in-chief of the journal Neurourology and Urodynamics from 2006-2016 and is on the editorial board of several international journals. He is an active member of many urological associations and societies including the British Association of Urological Surgeons, the European Association of Urology, the International Continence Society, the Association of Academic European Urologists and the American Association of Genitourinary Surgeons. He has chaired a number of guidelines initiatives including the NICE GDG on Male LUTS and the ICUD Consultation on Male LUTS. BAUS awarded him the St Peter’s medal 2011 and SUFU awarded him the Lifetime Achievement Award in 2015. Prof. Chapple has co-authored 750+ articles, comments and letters in peer-reviewed journals, and has written several chapters and books.

Presentation(s):

Send Email for Christopher Chapple

Alan J. Wein

University of Pennsylvania

Alan J Wein MD, PhD(hon), FACS, is the Founders Professor and Emeritus Chief of Urology and Director of the Residency Program at the University of Pennsylvania. He obtained his MD training in surgery, basic urologic research and clinical urology at Penn. He holds an honorary PhD from the University of Patras, Greece, and was conferred an Honorary Professorship by the Institute of Urology, Russian Ministry of Health. His clinical and research interests include, physiology/pharmacology of the lower urinary tract, evaluation/management of urinary incontinence and all types of lower urinary tract dysfunction, problems with prostate enlargement, evaluation/management of prostate, bladder and kidney cancer. He has received numerous awards for excellence in the field of urology, is recognized nationally and internationally through his many affiliations and professional memberships, which include the American Association of Genitourinary Surgeons, Clinical Society of Genitourinary Surgeons, American Surgical Association, Society of Surgical Oncology, Society of Urologic Oncology, Society of Pelvic Surgeons, Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction, Société Internationale d’Urologie, American Urological Association, and the Royal Society of Medicine. Awards include, the Urodynamics Society Lifetime Achievement Award, F. Brantley Scott Award of the American Foundation for Urologic Diseases, Hugh Hampton Young Award of the AUA, Ferdinand C. Valentine Award of the New York Academy of Medicine and the Keyes Medal by the AAGUS, which is recognized as the greatest individual citation in the specialty for outstanding contributions in the advancement of urology. He has authored or co-authored close to a thousand papers and book chapters, holds multiple editorial positions on scientific journals, has edited or co-edited over 30 books. Dr. Wein is editor-in-chief of the gold standard textbook in urology, Campbell-Walsh Urology. He is sought after and continues to lecture at all major urologic conferences held worldwide.

Presentation(s):

Send Email for Alan Wein


Assets

031IC - Contemporary Pharmacotherapy for OAB

Slides

Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for Contemporary Pharmacotherapy for OAB